World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT03053869
Date of registration: 13/02/2017
Prospective Registration: Yes
Primary sponsor: McMaster University
Public title: Benzodiazepine-free Anesthetic for Reduction of Delirium (B-Free) B-Free
Scientific title: Benzodiazepine-free Anesthetic for Reduction of Delirium (B-Free): A Two-centre Pilot Study to Determine the Feasibility of a Multi-centre, Randomized, Cluster Crossover Trial
Date of first enrolment: April 1, 2017
Target sample size: 480
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT03053869
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Prevention. Masking: None (Open Label).  
Phase:  Phase 1
Countries of recruitment
Canada
Contacts
Name:     Summer Syed, MD
Address: 
Telephone:
Email:
Affiliation:  McMaster University/Hamilton Health Sciences Corp.
Key inclusion & exclusion criteria

Inclusion Criteria:

- All patients undergoing cardiac surgery during the study period at the Hamilton
General and St. Boniface General Hospitals.

Exclusion Criteria:

-



Age minimum: 18 Years
Age maximum: N/A
Gender: All
Health Condition(s) or Problem(s) studied
Post-operative Delirium
Intervention(s)
Drug: Benzodiazepine - limited use strategy
Drug: Benzodiazepine - Ad libitum strategy
Primary Outcome(s)
Completion of a minimum of at least 1 CAM assessment per day [Time Frame: 1 day]
Confusion Assessment Method (CAM) assessment [Time Frame: 1 day]
Protocol adherence [Time Frame: 4-week crossover period]
Secondary Outcome(s)
In hospital mortality [Time Frame: 1-14 days]
Length of stay in Hospital [Time Frame: 5-14 days]
Delirium duration [Time Frame: 5-7 days]
Length of stay in the Intensive Care unit (ICU) [Time Frame: 1-3 days]
Secondary ID(s)
2159
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Hamilton Health Sciences Corporation
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history